Jashin J Wu (J J Wu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 37

Top Topics

Atopic Dermatitis

Top Venues

The Journal of dermatological treatment

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Sydney Thai, Joe Zhuo, Yichen Zhong, Qian Xia, Xiu Chen, Ying Bao, Devender Dhanda, Lawshia Priya, Jashin J Wu
Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies. The Journal of dermatological treatment 34 (1) (2023)
Brandon Smith, Priya Engel, Sogol Stephanie Javadi, Shivali Devjani, Peter Lio, Jashin J Wu
Association between atopic dermatitis and illicit drug use among US adults. International journal of dermatology (2023)
April W Armstrong, Manish Patel, Chao Li, Vishvas Garg, Monika Rao Mandava, Jashin J Wu
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. The Journal of dermatological treatment 34 (1) (2023)
Jashin J Wu, Ching An Wang, Greeta Jobson, David Davidson, Samaneh Kalirai, Julia Zhu, Manasi Suryavanshi, Mayank Mittal, Vardhaman Patel, Lauren Seigel
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis. The Journal of dermatological treatment 34 (1) (2023)
Sydney Thai, Joe Zhuo, Yichen Zhong, Qian Xia, Xiu Chen, Ying Bao, Devender Dhanda, Lawshia Priya, Jashin J Wu
Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies. The Journal of dermatological treatment (2023)
Alexandra Norden, Aislyn Oulee, Mirjana Ivanic, Sogol Stephanie Javadi, George Han, Jashin J Wu
The use of ultrasound to detect enthesitis as a potential guide for intervention in patients with psoriasis at risk of psoriatic arthritis: a systematic review. International journal of dermatology (2023)
Shivali Devjani, Priya Vedula, Stephanie Sogol Javadi, Brandon Smith, George Han, Jashin J Wu
Association of people with atopic dermatitis and household income among US adults in the 1999-2006 National Health and Nutrition Examination Survey. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Brandon Smith, Priya Engel, Michael R Collier, Shivali Devjani, Jacob Pontoppidan Thyssen, Jashin J Wu
Association between atopic dermatitis/eczema and arthritis among US adults. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jashin J Wu, Ching An Wang, Greeta Jobson, David Davidson, Samaneh Kalirai, Julia Zhu, Manasi Suryavanshi, Mayank Mittal, Vardhaman Patel, Lauren Seigel
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis. The Journal of dermatological treatment (2023)
April W Armstrong, Manish Patel, Chao Li, Vishvas Garg, Monika Rao Mandava, Jashin J Wu
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. The Journal of dermatological treatment (2023)
Sydney Thai, Sophie Barlow, James Lucas, James Piercy, Yichen Zhong, Joe Zhuo, Jashin J Wu
Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey. Dermatology and therapy (2023)
A Norden, J Y Moon, S S Javadi, L Munawar, Julia-Tatjana Maul, Jashin J Wu
Anti-drug antibodies of IL-23 inhibitors for psoriasis: a systematic review. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Jashin J Wu, Manasi Suryavanshi, David Davidson, Vardhaman Patel, Anuj Jain, Lauren Seigel
Economic Burden of Comorbidities in Patients with Psoriasis in the USA. Dermatology and therapy (2022)
Brandon Smith, Aislyn Oulee, Shivali Devjani, Michael R Collier, Alexander Egeberg, Jashin J Wu
Annual trends in Medicare part D prescription claims for calcipotriene/betamethasone dipropionate foam for psoriasis 2016-2020. International journal of dermatology (2022)
Alexandra Norden, Aislyn Oulee, Leena Munawar, Sogol Stephanie Javadi, George Han, Jashin J Wu
Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review. The Journal of dermatological treatment (2022)
Jashin J Wu, D G Kearns, T-C Lin, Vipawee S Chat, H J Litman, B Dube, R R McLean
Characterization of non-responders to interleukin-17 inhibitors in moderate to severe psoriasis patients enrolled in the Corrona® Psoriasis Registry. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
J Liu, A Martin, A Thatiparthi, Jashin J Wu
Association between atopic dermatitis and osteoarthritis among US adults in the 1999-2006 NHANES. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (6) (2021)
Aislyn Oulee, Sogol Stephanie Javadi, Amylee Martin, Tran H Do, Jashin J Wu
Phototherapy trends in dermatology 2015-2018. The Journal of dermatological treatment 33 (5) (2021)
Gil Yosipovitch, Marjolein de Bruin-Weller, April W Armstrong, Jashin J Wu, Pedro Herranz Pinto, Diamant Thaçi, Dimittri Delevry, Gaëlle Bégo-Le Bagousse, Raymond Zhang, Brad Shumel, Ana Beatris Rossi, Jingdong Chao
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 11 (6) (2021)
Donovan G Kearns, Shelley Uppal, Vipawee S Chat, Jashin J Wu
Use of systemic therapies for psoriasis in the COVID-19 era. The Journal of dermatological treatment (2021)
Kelly A Reynolds, Deeti J Pithadia, Erica B Lee, Wilson Liao, Jashin J Wu
Safety and Effectiveness of Anti-Tumor Necrosis Factor-Alpha Biosimilar Agents in the Treatment of Psoriasis. American journal of clinical dermatology 21 (4) (2021)
Zainab A Jafri, Shikha Walia, Mirjana G Ivanic, Jashin J Wu
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris. The Journal of dermatological treatment (2021)
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Alexander Egeberg, Jashin J Wu
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. American journal of clinical dermatology 22 (4) (2021)
Vipawee S Chat, Shelley K Uppal, Donovan G Kearns, Jashin J Wu
Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive review. Dermatologic therapy 34 (4) (2021)
Erica B Lee, Jashin J Wu
Safety of long-term interleukin-23 inhibition in patients with psoriasis. The British journal of dermatology 180 (5) (2020)
Jashin J Wu, Ryan W Harrison, Baojin Zhu, Orin M Goldblum, William N Malatestinic, Russel T Burge, Mwangi J Murage
Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry. Journal of comparative effectiveness research 10 (2) (2020)
Rima I Ghamrawi, Neda Ghiam, Jashin J Wu
Comparison of psoriasis guidelines for use of apremilast in the United States and Europe: a critical appraisal and comprehensive review. The Journal of dermatological treatment (2020)
Rima I Ghamrawi, Neda Ghiam, Jashin J Wu
Comparison of psoriasis guidelines for use of IL-23 inhibitors in the United States and United Kingdom: a critical appraisal and comprehensive review. The Journal of dermatological treatment (2020)
Jashin J Wu, Corey Pelletier, Brian Ung, Marc Tian, Ibrahim Khilfeh, Jeffrey R Curtis
Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics. Journal of comparative effectiveness research 9 (11) (2020)
E Fowler, R I Ghamrawi, N Ghiam, W Liao, Jashin J Wu
Risk of tuberculosis reactivation during interleukin-17 inhibitor therapy for psoriasis: a systematic review. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (7) (2020)
Erica B Lee, Kelly A Reynolds, Deeti J Pithadia, Alexander Egeberg, Jashin J Wu
Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review. The Journal of dermatological treatment 31 (4) (2019)
Lluis Puig, Jashin J Wu, Melinda J Gooderham, Yin You, Yaung-Kaung Shen, Bruce Randazzo, Francisco Kerdel
Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2. The Journal of dermatological treatment 32 (5) (2019)
Deeti J Pithadia, Kelly A Reynolds, Erica B Lee, Jashin J Wu
Psoriasis-associated itch: etiology, assessment, impact, and management. The Journal of dermatological treatment 31 (1) (2019)
Hasan Gökcer Tekin, Jashin J Wu, Russel T Burge, Julie A Birt, Alexander Egeberg
Burden and Disease Characteristics of Patients with Psoriatic Arthritis: A Population-based Cross-sectional Study. The Journal of rheumatology 46 (7) (2019)
Deeti J Pithadia, Kelly A Reynolds, Erica B Lee, Wilson Liao, Jashin J Wu
Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy. Therapeutic advances in chronic disease 10 (2019)
Erica B Lee, Mina Amin, Alexander Egeberg, Jashin J Wu
Treatment changes in patients with psoriasis on etanercept or adalimumab: a retrospective chart review. The Journal of dermatological treatment 29 (7) (2018)
Erica B Lee, Mina Amin, Jeremy Man, Alexander Egeberg, Jashin J Wu
Rates of latent tuberculosis infection in patients treated with TNF inhibitors for psoriasis: a retrospective chart review. The Journal of dermatological treatment 29 (7) (2018)